Latest Breaking News On - நிறுவனம் மைமோனிட்கள் - Page 2 : comparemela.com
El Ayuntamiento de Córdoba y Fundecor promueven la conexión entre jóvenes cordobeses y jóvenes europeos para fomentar el emprendimiento
eldiadecordoba.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eldiadecordoba.es Daily Mail and Mail on Sunday newspapers.
Marcha por la Vida: el CEO de Pfizer habló sobre la lucha de sus padres durante el Holocausto
infobae.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infobae.com Daily Mail and Mail on Sunday newspapers.
«Sabemos más sobre la covid, pero aún quedan muchísimas incertidumbres»
ideal.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ideal.es Daily Mail and Mail on Sunday newspapers.
Blanca Torrent: «Nos permite crear nuevas oportunidades de empleo»
diariocordoba.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from diariocordoba.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Skye Bioscience Appoints Cannabinoid Science Experts Giovanni Appendino, PhD and Eduardo Muñoz, .
Skye Bioscience, Inc.March 8, 2021 GMT
San Diego, Calif., March 08, 2021 (GLOBE NEWSWIRE) Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, announced today the appointment of scientific innovators and cannabinoid experts, Giovanni Appendino, PhD and Eduardo Muñoz, MD, PhD to its scientific advisory board.
“We are honored to welcome two of the world’s most influential thought leaders in cannabinoid science, Drs. Appendino and Muñoz, to our scientific advisory board as we continue to advance our research and deepen our understanding of cannabinoid-based medicines,” said Punit Dhillon, Chief Exec